definiens: shall mean the treatment or prevention of the following indica.tions irrespective of the mechanism of action to achieve the desired therapeutic effect : i. Diabetes, Impaired Fasting Glucose, Impaired Glucose Tolerance, and Reduction of serum / plasma glucose levels ; 11 . Inflammatory Bowel Syndrome ( IBS ) ; and 111 . Syndrome X ( Dysmetabolic Syndrome ) shall mean the following [COMPANY] pending patent a.pplications : 2.2 The existing definitions in Article 1 of the terms referenced below shall be deleted in their entirety and replaced in full with the definitions set forth below : shall mean the ( i ) subject matter related to the development, manufacture, use, offer for sale or sale of Product in the Field but not in the Expanded Field, claimed in or covered by the pending patent application and issued patents recited in Exhibit B ; and any continuations, continuations - in - part, divisionals and foreign counterpart application thereof and in any patents issuing on these applications, including reissues and re­examinations ; and ( ii ) Patent Rights claiming GeITexInventions or Joint Inventions ( as such terms are defined in Section 7.1.1 ) to the extent such Patent Rights relate to or are necessary or useful for the development, manufacture, use, offer for sale or sale of Product and [COMPANY] agrees that such Patent Rights should be included in [COMPANY] Patent Rights